What a surprise (NOT) no coverage in the US Press. Go Buffalo, keep up the good work!
Researchers at the University at Buffalo are about to launch North America's first clinical trial to test the said...
iberation treatment," an experimental therapy designed to halt the symptoms of multiple sclerosis."]
CMAJ Editor-in-Chief Dr. Paul Hebert and Deputy Editor Dr. Matthew Stanbrook note that several MPs in Ottawa have recently lobbied the federal government to invest in research into the controversial treatment. They note, as well, that patients have held well-publicized demonstrations, demanding access to the liberation procedure -- which they applaud.
Patients should insist on evidence. They should also insist on having their views represented when decisions about where to spend research dollars are made, said...
the editors write.]
Learning and living everyday to the fullest. My MS blog http://mylifewms.blogspot.com/
Post Edited (Dave_NC) : 6/28/2010 3:15:43 PM (GMT-6)